Novel Approaches To Tackling Obesity, Cancer And MRSA

Main Category: Obesity / Weight Loss / Fitness
Also Included In: Cancer / Oncology;  MRSA / Drug Resistance;  Pharma Industry / Biotech Industry
Article Date: 17 Jan 2007 - 23:00 PDT

email to a friend   printer friendly   opinions  

Obesity, cancer and the hospital 'superbug' MRSA are the targets for novel drugs being developed under a new scheme funded by the Wellcome Trust. The Seeding Drug Discovery initiative aims to bridge the funding gap for health researchers involved in early-stage drug discovery projects that will be the springboard for further research and development by the biotech and pharmaceutical industry.

Speakers:

* Seeding Drug Discovery - Dr Ted Bianco (Technology Transfer Division, Wellcome Trust)

* Natural gut hormone offers hope for new obesity drug - Professor Steve Bloom (Imperial College London)

* New antibacterials being developed to tackle MRSA -Dr Lloyd Czaplewski (Prolysis)

* Novel approach to cancer drug - Professor Jeremy Tavaré (University of Bristol)

###

Contact: Craig Brierley
Wellcome Trust

• Additional
• References
• Citations